LOL - so much for supreme court overturning breast cancer patents !!
But Myriad this week sued two of those competitors Ambry Genetics and Gene by Gene saying their tests infringed some of the more than 500 other patent claims that were not invalidated by the Supreme Court, for instance, on synthetic DNA used as probes and on methods of testing.
Both suits were filed in Federal District Court in Salt Lake City, where Myriad is based. Myriad is seeking preliminary injunctions to stop the competitors from offering BRCA tests. It is also seeking damages, which could be tripled if the court found that the infringement had been willful.
These patent games will continue to keep US healthcare costs very high, because -
God Darwin forbid, if US government joins the mess by adding
another few 5,000 page laws to ‘fix’ the problem.